2020 Generic and Specialty Drug Companies: Capabilities, Goals and Strategies

In the dynamic and fragmented Generic and Specialty Drug industry, besieged by intense competition and rapid change of technological innovations, the ability to anticipate new product introductions and marketing strategies is particularly important...and can spell the difference between success and failure.

Our collection of strategic assessments of leading Generic and Specialty Drug companies provides significant competitor information, analysis and insight critical to the development and implementation of effective business, marketing and R&D programs. The assessments include latest organizational and management developments, acquisitions and divestitures, marketing tactics, financial results, strengths and weaknesses, and strategic directions.

Aurora Cannabis
Canopy Growth
Cronos Group
Curaleaf
Dr. Reddys Laboratories
Green Thumb
Merck
MomentaPharma
Mylan
Perrigo
Teva Pharma
Tilray
oetis

These reports will complement your internal competitor information gathering efforts with objective strategic analysis, data interpretation and insight.

The reports will also assist current competitors and potential market entrants in evaluating prospective acquisitions and joint venture candidates.

Pharmaceutical and Healthcare Sector Mergers, Acquisitions and Investment Trend Annual Review - 2020

Pharmaceutical and Healthcare Sector Mergers, Acquisitions and Investment Trend Annual Review - 2020GlobalDatas Pharmaceutical and Healthcare Sector Mergers, Acquisitions and Investment Trend Annual Review - 2020 report is an essential

USD 3500 View Report

Clinical Trials - A Scorecard for Clinical Trial Investigations in 2020

Clinical Trials - A Scorecard for Clinical Trial Investigations in 2020The purpose of this report is to provide insight into the clinical trial landscape for 2020, an analyses of the

USD 695 View Report

2021 Generic and Specialty Drug Companies: Capabilities, Goals and Strategies

In the dynamic and fragmented Generic and Specialty Drug industry, besieged by intense competition and rapid change of technological innovations, the ability to anticipate new product introductions and marketing strategies

USD 9500 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available